Validate tool for pain assessment in cardiac surgery
How do you measure the pain of a patient who can’t communicate? A Rhode Island Hospital researcher studied an observational pain scale in cardiac surgery patients, and found… read more.
How do you measure the pain of a patient who can’t communicate? A Rhode Island Hospital researcher studied an observational pain scale in cardiac surgery patients, and found… read more.
by Bruce Sylvester – A new analysis of over 1 million hospital admissions in US hospitals revealed that over half of all nonsurgical patients were prescribed opioids during… read more.
Birgitte Pedersen et al, Vejle Hospital, Denmark. Patients with colorectal cancer (CRC) face huge challenges in their everyday lives as a result of their condition and treatments.
Oral discussion of abstract by Professor Naredi, Sahlgrenska University Hospital, Gothenburg, Sweden. Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer.
by Peter Mas Mollinedo reporting on the presentation by Dominique Elias, Gustave-Roussy Institute, Paris, France. – Aggressive complete cytoreductive surgery (CCRS) in combination with hyperthermic intraperitoneal chemotherapy (HIPEC)… read more.
LM Wiltink, Leiden University Medical Center, the Netherlands; Hans-Joachim Schmoll, Martin Luther University Halle – Wittenberg, Germany. A unique 14-year follow-up study from the universities of Leiden in… read more.
Report from the Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. In a clinical trial, a self-expanding transcatheter aortic valve met the key… read more.
Report by Esther Drain – Cetuximab resulted in a significant improvement in survival in TP53 WT, high-risk Rectal Cancer.
Investigators reported on Oct. 22 in the Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) that treatment with adalimumab may be effective for patients with steroid-resistant… read more.
Bernhard Banas, Regensburg, Germany – Prolonged-release tacrolimus administered once-daily provides high rates of graft survival and reduction in biopsy-confirmed acute rejection (BCAR), with a manageable tolerability profile, in patients… read more.
by Pavel Trunečka, Prague, Czech Republic – Starting on a low dose of prolonged-release, once-daily tacrolimus after liver transplantation achieved better renal function and a significantly lower risk… read more.
Re-transplantation is the only option available for salvaging a failed abdominal graft. As the outcomes after primary transplantations continue to improve, even with the increasing use of extended-criteria… read more.